Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avalon BioVentures is an active San Diego-based venture capital firm specializing in early-stage life sciences innovation. Through its ABV Accelerator program and hands-on approach, it forms and supports pioneering biotech startups that have advanced drug candidates across multiple indications. Its track record includes successful exits such as Synthorx (acquired by Sanofi), Calporta (acquired by Merck), Sitari Pharmaceuticals (acquired by GSK), Janux Therapeutics (IPO), PDI Therapeutics (acquired by Cullinan Oncology), Nerio Therapeutics ($1.3B acquisition by Boehringer Ingelheim). Portfolio companies have reached clinical stages rapidly due to Avalon's integrated support infrastructure
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avalon BioVentures.